Bioretecs RemeO's Screw LAG Solid Receives CMS Transitional Pass-Through Payment in US. Read more.
Cantargia appoints Dr. Wolfram Dempke to the Chief Medical Officer. Read more.
Circio informs about the approval and publication of prospectuses for potential future new issues and conversion of convertible bonds. Read more.
Corline announces that Kardium has begun commercializing the Globe system in the United States. Read more.
Enzymatica becomes the official supplier to the Swedish Biathlon Association. Read more.
Hansa Biopharma intends to carry out a directed new share issue of approximately USD 60 million. Read more. A private placement of 17 million shares has been completed, raising approximately USD 71 million for the company. Read more. The company also publishes information documents for admission to trading of shares on Nasdaq Stockholm. Read more.
Inhalation Sciences receives service orders from recurring global pharmaceutical customers. Read more.
IRLAB is advancing the fully funded study of IRL757 in Parkinson's disease in collaboration with MSRD. Read more.
Magle Group obtains registration of SmartPAN in Singapore, enabling launch in pancreatic surgery. Read more.
Medcaps subsidiary Abilia acquires LivAssured. Read more.
Mendus announces updated clinical strategy and operational focus. Read more.
Nanexa changes Certified Adviser to Tapper Partners. Read more.
Nanologica enters the insulin market in China. Read more.
SensoDetect accelerates international collaborations to promote early screening and diagnostic support tools for autism and ADHD. Read more.
SoftOx Solutions has submitted an application for a clinical trial for dose escalation in a phase IIa study for cystic fibrosis. Read more.
SpectraCure appoints Johannes Swartling to CEO. Read more.
ZymIQ signs new distribution agreement for Malaysia. Read more.
Invitations & presentations
Reports
Nomination committees
The latest from BioStock
» NanoEcho one year after listing: clinical validation on the agenda
» Orexo secures at least 75 million for overdose treatment
» Fluicell marks major milestones
» Green Light for Higher Doses in Isofol’s Arfolitixorin Study
» PHI gears up for next-gen launch after strong year